This is a research study designed to see if sparsentan, an investigational drug, is effective in treating participants with recurrence of IgAN or FSGS in their kidney transplant by lowering the amount of protein in the urine and whether sparsentan causes side effects.
During the study, you will be asked questions about you and your medical history, complete physical exams, complete vital signs (blood pressure, heart rate, height and weight), as well as blood and urine tests.
$150 debit card for each completed visit up to a total of $1500. Mileage reimbursement up to $126 per visit based on the current, federal business mileage rate.
Clinical and Translational Research Center (CTRC)
Burnett-Womack Building (UNC-Chapel Hill)
160 Dental Cir, Chapel Hill, NC 27514, USA
UNC Eastowne Medical Office Building
100 Eastowne Dr, Chapel Hill, NC 27514, USA
Elizabeth Kotzen
Medicine-Nephrology
Clinical or Medical
Interventional
Kidneys and Liver
Transplant
25-1336
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
